Predict your next investment

Hedge Fund
rockspringscapital.com

See what CB Insights has to offer

Investments

114

Portfolio Exits

78

Funds

1

About Rock Springs Capital

Rock Springs Capital is a hedge fund created by Kris Henner to invest in healthcare and biotechnology stocks.

Rock Springs Capital Headquarter Location

650 S Exeter Street 10th Floor

Baltimore, Maryland, 21202,

United States

410-220-0130

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Rock Springs Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Rock Springs Capital in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Rock Springs Capital News

Immunocore to raise $140M in private placement financing

Jul 18, 2022

Immunocore (NASDAQ: IMCR ) agreed to sell 3.7M shares, consisting of 2M ADSs with each ADS representing one ordinary share, and 1.7M non-voting ordinary shares, to certain institutional accredited investors through a private investment in public equity financing at a price per ADS/non-voting ordinary share of $37.50. The PIPE financing included participation from existing investors including RTW Investments, LP, Rock Springs Capital, and General Atlantic. Net proceeds to be used for funding its oncology and infectious disease clinical pipeline including the continued clinical development of tebentafusp in advanced cutaneous melanoma and ImmTAC clinical candidates targeting MAGE-A4 and PRAME. Offer closing is expected to occur on or about July 20, 2022. "The proceeds from the private placement, combined with anticipated KIMMTRAK revenue in metastatic uveal melanoma, and cash on hand are expected to fund our current operating plan through 2025," CFO & Head of Strategy Brian Di Donato commented. Recommended For You

Rock Springs Capital Investments

114 Investments

Rock Springs Capital has made 114 investments. Their latest investment was in Delfi Diagnostics as part of their Series B on July 7, 2022.

CBI Logo

Rock Springs Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/18/2022

Series B

Delfi Diagnostics

$225M

No

4

6/8/2022

Series B

Mineralys Therapeutics

$118M

Yes

6

5/10/2022

Series B

MOMA Therapeutics

$150M

No

7

1/5/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/26/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/18/2022

6/8/2022

5/10/2022

1/5/2022

10/26/2021

Round

Series B

Series B

Series B

Series A

Series A

Company

Delfi Diagnostics

Mineralys Therapeutics

MOMA Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$225M

$118M

$150M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

6

7

10

10

Rock Springs Capital Portfolio Exits

78 Portfolio Exits

Rock Springs Capital has 78 portfolio exits. Their latest portfolio exit was Disc Medicine on August 10, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/10/2022

Acq - Pending

$99M

3

5/31/2022

Acquired

$99M

6

1/7/2022

IPO

$99M

Public

5

1/7/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

1/7/2022

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/10/2022

5/31/2022

1/7/2022

1/7/2022

1/7/2022

Exit

Acq - Pending

Acquired

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

3

6

5

10

10

Rock Springs Capital Fund History

1 Fund History

Rock Springs Capital has 1 fund, including Rock Springs Capital Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/14/2013

Rock Springs Capital Fund

$101.4M

1

Closing Date

10/14/2013

Fund

Rock Springs Capital Fund

Fund Type

Status

Amount

$101.4M

Sources

1

Rock Springs Capital Team

3 Team Members

Rock Springs Capital has 3 team members, including current Chief Executive Officer, Christopher Yoshida.

Name

Work History

Title

Status

G. Margraf Bussard

Founder

Current

Kris Jenner

T. Rowe Price, and Harvard Medical School

Founder

Current

Christopher Yoshida

Chief Executive Officer

Current

Name

G. Margraf Bussard

Kris Jenner

Christopher Yoshida

Work History

T. Rowe Price, and Harvard Medical School

Title

Founder

Founder

Chief Executive Officer

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.